Skip to main content

KU 430 Pill - purple white capsule/oblong, 19mm

Pill with imprint KU 430 is Purple / White, Capsule/Oblong and has been identified as Lansoprazole Delayed-Release 30 mg. It is supplied by Lannett Company, Inc.

Lansoprazole is used in the treatment of Barrett's Esophagus; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; GERD; Erosive Esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 430

Lansoprazole delayed-release 30 mg KU 430
Lansoprazole delayed-release 30 mg KU 430

Lansoprazole Delayed-Release

Imprint
KU 430
Strength
30 mg
Color
Purple / White
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
62175-0430
Inactive Ingredients
FD&C Blue No. 1, FD&C Red No. 3, gelatin, hypromellose 2910 (6 mPa.s), magnesium carbonate, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 6000, polysorbate 80, sodium lauryl sulfate, sodium starch glycolate type A corn, magnesium silicate, titanium dioxide, shellac, isopropyl alcohol, butyl alcohol, ammonia, alcohol, ferrosoferric oxide, aluminum chlorohydrex propylene glycol

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer